Method of treating mood disorders and/or anxiety disorders...

Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C607S003000, C607S117000, C600S378000

Reexamination Certificate

active

11118140

ABSTRACT:
The present invention involves a method and a system for using electrical stimulation and/or chemical stimulation to treat depression. More particularly, the method comprises surgically implanting an electrical stimulation lead and/or catheter that is in communication with a predetermined site which is coupled to a signal generator and/or infusion pump that release either an electrical signal and/or a pharmaceutical resulting in stimulation of the predetermined site thereby treating the mood and/or anxiety disorder.

REFERENCES:
patent: 3653385 (1972-04-01), Burton
patent: 3731681 (1973-05-01), Blackshear et al.
patent: 3951147 (1976-04-01), Tucker et al.
patent: 4692147 (1987-09-01), Duggan
patent: 4772263 (1988-09-01), Dorman et al.
patent: 4883057 (1989-11-01), Broderick
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 5119832 (1992-06-01), Xavier
patent: 5125888 (1992-06-01), Howard et al.
patent: 5263480 (1993-11-01), Wernicke et al.
patent: 5299569 (1994-04-01), Wernicke et al.
patent: 5342410 (1994-08-01), Braverman
patent: 5423877 (1995-06-01), Mackey
patent: 5458631 (1995-10-01), Xavier
patent: 5470846 (1995-11-01), Sandyk et al.
patent: 5540734 (1996-07-01), Zabara et al.
patent: 5585118 (1996-12-01), Stoll
patent: 5601835 (1997-02-01), Sabel et al.
patent: 5683422 (1997-11-01), Rise
patent: 5707335 (1998-01-01), Howard et al.
patent: 5711316 (1998-01-01), Elsberry et al.
patent: 5713923 (1998-02-01), Ward et al.
patent: 5716377 (1998-02-01), Rise et al.
patent: 5735505 (1998-04-01), Walton
patent: 5735814 (1998-04-01), Elsberry et al.
patent: 5750103 (1998-05-01), Cherksey
patent: 5752911 (1998-05-01), Canedo et al.
patent: 5779694 (1998-07-01), Howard et al.
patent: 5792186 (1998-08-01), Rise
patent: 5814014 (1998-09-01), Elsberry et al.
patent: 5832932 (1998-11-01), Elsberry et al.
patent: 5833709 (1998-11-01), Rise et al.
patent: 5840069 (1998-11-01), Robinson
patent: 5853385 (1998-12-01), Emerich et al.
patent: 5873849 (1999-02-01), Bernard
patent: 5921245 (1999-07-01), O'Donnell, Jr.
patent: 5938688 (1999-08-01), Schiff
patent: 5975085 (1999-11-01), Rise
patent: 5978702 (1999-11-01), Ward et al.
patent: 6015786 (2000-01-01), Mascarenhas et al.
patent: 6016449 (2000-01-01), Fischell et al.
patent: 6036459 (2000-03-01), Robinson
patent: 6042579 (2000-03-01), Elsberry et al.
patent: 6051017 (2000-04-01), Loeb et al.
patent: 6093180 (2000-07-01), Elsberry
patent: 6094598 (2000-07-01), Elsberry et al.
patent: 6128537 (2000-10-01), Rise
patent: 6129685 (2000-10-01), Howard, III
patent: 6132361 (2000-10-01), Epstein et al.
patent: 6161045 (2000-12-01), Fischell et al.
patent: 6176242 (2001-01-01), Rise
patent: 6216030 (2001-04-01), Howard et al.
patent: 6227203 (2001-05-01), Rise et al.
patent: 6230049 (2001-05-01), Fischell et al.
patent: 6248126 (2001-06-01), Lesser et al.
patent: 6251115 (2001-06-01), Williams et al.
patent: 6251669 (2001-06-01), Luskin
patent: 6263237 (2001-07-01), Rise
patent: 6278895 (2001-08-01), Bernard
patent: 6353754 (2002-03-01), Fischell et al.
patent: 6353762 (2002-03-01), Baudino et al.
patent: 6356784 (2002-03-01), Lozano et al.
patent: 6366813 (2002-04-01), DiLorenzo
patent: 6399574 (2002-06-01), McCabe et al.
patent: 6418344 (2002-07-01), Rezai et al.
patent: 6425852 (2002-07-01), Epstein et al.
patent: 6463328 (2002-10-01), John
patent: 6473639 (2002-10-01), Fischell et al.
patent: 6514937 (2003-02-01), Mascarenhas
patent: 6539263 (2003-03-01), Schiff et al.
patent: 6567696 (2003-05-01), Voznesensky et al.
patent: 6591138 (2003-07-01), Fischell et al.
patent: 6592509 (2003-07-01), Hunter, Jr.
patent: 6594880 (2003-07-01), Elsberry
patent: 6597954 (2003-07-01), Pless et al.
patent: 6609030 (2003-08-01), Rezai et al.
patent: 6609031 (2003-08-01), Law et al.
patent: 6620151 (2003-09-01), Blischak et al.
patent: 6629973 (2003-10-01), Wardell et al.
patent: 6666845 (2003-12-01), Hooper et al.
patent: 6708064 (2004-03-01), Rezai
patent: 6712753 (2004-03-01), Manne
patent: 6735474 (2004-05-01), Loeb et al.
patent: 6735475 (2004-05-01), Whitehurst et al.
patent: 6782292 (2004-08-01), Whitehurst
patent: 6819956 (2004-11-01), DiLorenzo
patent: 6871098 (2005-03-01), Nuttin et al.
patent: 6898455 (2005-05-01), Anderson et al.
patent: 6907280 (2005-06-01), Becerra et al.
patent: 2002/0013612 (2002-01-01), Whitehurst
patent: 2002/0058867 (2002-05-01), Breiter et al.
patent: 2002/0062143 (2002-05-01), Baudino et al.
patent: 2002/0091419 (2002-07-01), Firlik et al.
patent: 2002/0151939 (2002-10-01), Rezai
patent: 2002/0169485 (2002-11-01), Pless et al.
patent: 2003/0028072 (2003-02-01), Fischell et al.
patent: 2003/0032001 (2003-02-01), Broderick
patent: 2003/0097159 (2003-05-01), Schiff et al.
patent: 2003/0149457 (2003-08-01), Tcheng et al.
patent: 2003/0181954 (2003-09-01), Rezai
patent: 2004/0092010 (2004-05-01), Altaba et al.
patent: 2005/0027284 (2005-02-01), Lozano et al.
patent: 2005/0033379 (2005-02-01), Lozano et al.
patent: 2005/0143799 (2005-06-01), Black et al.
patent: 2005/0143800 (2005-06-01), Lando et al.
patent: WO-0197906 (2001-12-01), None
patent: WO-03043690 (2003-05-01), None
patent: WO-03063951 (2003-08-01), None
Hanamori, Takamitsu. Chemical Stimulation of the Thalamic Reticular Nucleus Inhibits the Neuronal Activity of the Posterior Insular Cortex in Rats. Chemical Senses, vol. 28, No. 8, pp. 717-728. Oxford University Press, 2003.
Barbas et al, “Projections from the Amygdala to Basoventral and Mediodorsal Prefrontal Regions in the Rhesus Monkey,” The Journal of Comparative Neurology vol. 300, 1990, pp. 549-571.
Barbas et al, “Topographically Specific Hippocampal Projections Target Functionally Distinct Prefrontal Areas in the Rhesus Monkey,” Hippocampus vol. 5, 1995, pp. 511-533.
Bjorklund et al, “Cell Replacement therapies for Central Nervous System Disorders,” Nature Neuroscience vol. 3, No. 6, Jun. 2000, pp. 537-544.
Bremmer, J.D., “Structural Changes in the Brain in Depression and relationship to Symptom Recurrence,” CNS Spectrums, vol. 7, No. 2, Feb. 2002, pp. 129-139.
Caetano et al, “Anatomical MRI Study of Hippocampus and Amygdala in Patients with Current and Remitted Major Depression,” Psychiatry Research: Neuroimaging vol. 132, 2004, pp. 141-147.
Capel et al, “The influence of electrostimulation on hexobarbital induced loss of righting reflex in rats,”Acupunct. Electrother. Res.7(1): 17-26, 1982.
Cosgrove et al, “Psychosurgery,” Neurosurgery Clinicls of North America vol. 6 No. 1, Jan. 1995, pp. 167-176.
Delbello et al, “Magnetic Resonance Imaging Analysis of Amygdala and other Subcortical Brain Regions in Adolescents with Bipolar Disorders,” Bipolar Disorders vol. 6, 2004, pp. 43-52.
Diamond et al, “Preclinical Research on Stress, Memory and the Brain in the Development of Pharmacotherapy for Depression,” European Neuropsychopharmacology vol. 14, 2004 pp. S491-S495.
Dougherty et al., “Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression,”J. Neurosurg., 99(6): 1010-7, 2003.
Drevets et al, “Functional Anatomical Correlates of Antidepressants Drug Treatment Assessed Using PET Measures of Regional Glucose Metabolism,” European Neuropsychopharmacology vol. 12, 2002, pp. 527-544.
Drevets et al, “Subgenual Prefrontal Cortex Abnormalities in Mood Disorders,” Nature vol. 386, Apr. 24, 1997, pp. 824-827.
Ebmeier et al, “Cerebral Perfusion Correlates of Depressed Mood,” British Journal of Psychiatry vol. 178, 1997, pp. 77-81.
Fossati et al, “Neuroplasticity: from MRI to Depressive Symptoms,” European Neuropsychopharmacology vol. 14, 2004, pp. S503-S510.
Galynker et al, “Hypofrontality and Negative Symptoms in Major Depressive Disorder,” The Journal of Nuclear Medicine vol. 39, No. 4, Apr. 1998, pp. 608-612.
Goldapple et al, “Modulation of Cortical-Limbic Pathways in Major Depression,” Arch Gen Psychiatry vol. 61, Jan. 2004, pp. 34

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating mood disorders and/or anxiety disorders... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating mood disorders and/or anxiety disorders..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating mood disorders and/or anxiety disorders... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3863396

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.